site stats

Fbxl2 egfr

TīmeklisSource data are provided as a Source data file. from publication: FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth Abnormal … Tīmeklis2016. gada 21. marts · FBXL2 (F-Box And Leucine Rich Repeat Protein 2) is a Protein Coding gene. Diseases associated with FBXL2 include Hepatitis C Virus . Gene Ontology (GO) annotations related to this gene include ubiquitin-protein transferase activity and protein phosphatase binding . An important paralog of this gene is FBXL20.

FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR …

Tīmeklis2024. gada 9. okt. · Epidermal growth factor receptor (EGFR) activation plays a pivotal role in EGFR-driven non-small cell lung cancer (NSCLC) and is considered as a key … TīmeklisEGFR mutations-mediated resistance to tyrosine-kinase inhibitors (TKIs) is a major hurdle for NSCLC treatment. Here, we show that F-box protein FBXL2 targets EGFR … linda camfield bacliffe tx https://opti-man.com

Frontiers Targeting F-Box Protein Fbxo3 Attenuates Lung Injury ...

TīmeklisCN113663070A CN202410721276.9A CN202410721276A CN113663070A CN 113663070 A CN113663070 A CN 113663070A CN 202410721276 A CN202410721276 A CN 202410721276A CN 113663070 A CN1136630 TīmeklisEGFR mutations-mediated resistance to tyrosine-kinase inhibitors (TKIs) is a major hurdle for NSCLC treatment. Here, we show that F-box protein FBXL2 targets EGFR and EGFR TKI-resistant mutants for proteasome-mediated degradation, resulting in suppression of EGFR-driven NSCLC growth. Tīmeklis2024. gada 16. okt. · 该团队原创性地发现F-box蛋白FBXL2是EGFR的新的E3泛素连接酶，可促进EGFR的多泛素化蛋白酶体途径的降解，从而抑制EGFR驱动的非小细胞肺 … linda capps facebook

FBXL2 F-box and leucine rich repeat protein 2 [ (human)]

Category:Recombinant Human EGF Protein, CF 236-EG-200: R&D Systems

Tags:Fbxl2 egfr

Fbxl2 egfr

FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR …

TīmeklisNational Center for Biotechnology Information Tīmeklis2024. gada 12. aug. · FBXL2 is indispensible regulator of mitosis that serves as a tumor suppressor FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation. FBL2 is a novel and dual regulator of amyloid precursor protein (APP) metabolism through FBL2-dependent ubiquitination of APP.

Fbxl2 egfr

Did you know?

Tīmeklis2024. gada 11. okt. · FBXL2 binds to and promotes EGFR for polyubiquitin- and proteasome-mediated degradation in an EGF-independent manner. EGFR protein … TīmeklisSee all FBXL2 primary antibodies Description Goat polyclonal to FBXL2 Host species Goat Tested applications Suitable for: IHC-P, WB more details Species reactivity …

Tīmeklis2024. gada 11. okt. · Thus, FBXL2 binds to and promotes polyubiquitin of EGFR, resulting in proteasome-mediated degradation of EGFR. FBXL2 targets on the … We would like to show you a description here but the site won’t allow us. TīmeklisTherefore, FBXL2-mediated EGFR protein degradation is inde-pendent of EGF stimulation. We next investigated whether FBXL2 is a bona de E3 ubiquitin ligase for …

TīmekliseGFR Calculator. Glomerular filtration rate (GFR) is the best overall index of kidney function. Normal GFR varies according to age, sex, and body size, and declines with age. The National Kidney Foundation recommends using the CKD-EPI Creatinine Equation (2024) to estimate GFR. More information regarding this recommendation … TīmeklisK10268 FBXL2_20; F-box and leucine-rich repeat protein 2/20. Ubiquitin system [BR: ko04121] Ubiquitin ligases (E3) Multi subunit Ring-finger type E3. SCF complex. Target recognizing subunit (F-box) K10268 FBXL2_20; F-box and leucine-rich repeat protein 2/20. BRITE hierarchy.

TīmeklisFBXL2. General description of the gene and the encoded protein (s) using information from HGNC and Ensembl, as well as predictions made by the Human Protein Atlas …

TīmeklisFBXL2. F-box/LRR-repeat protein 2 is a protein that in humans is encoded by the FBXL2 gene. [4] [5] [6] This gene encodes a member of the F-box protein family … linda cannon realtor hotchkiss coloradoTīmeklis2024. gada 11. okt. · EGFR mutations-mediated resistance to tyrosine-kinase inhibitors (TKIs) is a major hurdle for NSCLC treatment. Here, we show that F-box protein … linda caplinger maxwellTīmeklis2024. gada 15. jūl. · Increasing Fbxl2 levels with nebivolol (102) (Fig. 14) in combination with osimertinib or a Grp94 inhibitor (ganetespib) to target the FBXL2-Grp94-EGFR axis and thus destabilize EGFR is a possible therapeutic strategy to overcome resistance to third-generation EGFR-TKIs . AKR1B1 inhibitors linda canup white fnp